【レポートの概要（一部）】
1. Executive Summary
2. What are Biosimilars?
3. Emergence of Biosimilars
3.1 Role of the Biologics Price Competition and Innovation (BPCI) ACT
3.2 Issue of Data Exclusivity
4. Industry Definition
4.1 Defining Biosimilars
4.2 Specificity of Biosimilars
4.3 Categories of Biologics
4.4 Importance of Biosimilars
4.5 Comparing Biosimilars with Generics
4.6 Branded Product Business Model
5. Overview of the Biopharmaceutical Industry
5.1 Market Profile
5.2 Biopharmaceutical Manufacturing Process
6. Global Biosimilars Market Statistics
6.1 Market Profile
6.2 Market Size
6.3 Market Value of Branded Biologics Facing Patent Expiry
6.4 Operating Margin for Biosimilar Manufacturers
6.5 Investor Concerns regarding Biosimilars
6.6 Commercial Impact of the European Biosimilars Industry
7. Key Success Factors for Biosimilars
7.1 Long Term Strategy
7.2 Developing Competitive Intelligence
7.3 Proper Financial Structure
7.4 Developing Key Biomanufacturing Competencies
7.5 Developing Clinical Capabilities and Regulatory Expertise
7.6 Well Developed Sales and Distribution Channels
8. Factors Impacting the Global Biosimilars Industry
8.1 Growth of the Industry in Developed Countries
8.2 Growth of the Industry in BRIC Countries
8.3 High Cost of Biologics
8.4 Use of Branded Biologics to Increase
8.5 Introduction of Approval Pathways in the US and Japan
8.6 EU’s Draft on Biosimilar Monoclonal Antibody Guidance
8.7 Unfavorable Tendering Procedures
8.8 Problem of Reference Pricing
8.9 Strategy of Biosimilar Companies with Regards to Hospital and Retail Setting
8.10 Issue of Biosimilar Comparability
8.11 Lack of Incentives, Service Agreements and Marketing Costs
8.12 Availability of Second Generation Branded Biologics
8.13 No Automatic Substitution of Branded Biologics
8.14 Cost-containment to Boost Uptake of Biosimilars
8.15 Lack of Proper IP Protection in Emerging Countries
8.16 Ease of Market Entry in BRIC Countries
8.17 Strong Biologic Capabilities in BRIC Countries
8.18 Restricted Market Access for Domestic Players in Emerging Countries
8.19 Problem of Low Purchasing Power in Emerging Markets
9. Biosimilar Market Drivers & Challenges
9.1 Factors Driving Growth of Biosimilars
9.1.1 Need to Lower Healthcare Costs
9.1.2 Lower Development Costs of Biosimilars as compared to New Biologic Drug
9.1.3 Lower Cost of Treatment with Biosimilars
9.1.4 Upcoming Patent Expiries for Blockbuster Biologics
9.1.5 Large Sales of Biologic Drugs
9.1.6 Greater Profitability of Biosimilars as compared to Generic Drugs
9.2 Factors Restraining the Growth of Biosimilars
9.2.1 Lack of Automatic Substitution
9.2.2 High Cost of Development and Manufacturing as compared to Generics
9.2.3 High Entry Barriers to the Biosimilar Industry
9.2.4 Emergence of Second Generation Biologic Drugs
9.2.5 Patent Protection for Biologic Drugs
10. Regulatory Framework
10.1 Regulatory Framework in Europe
10.1.1 EMEA’s Current Position
10.1.2 Bolar Type Provision
10.1.3 Comparability Exercises
10.1.4 Approval Process for Biosimilars
10.2 Regulatory Framework in Japan
10.2.1 Current Position on Biosimilars
10.3 Regulatory Framework in the USA
10.3.1 BPCIA and the Approval Pathway for Biosimilars
10.3.1.1 Role of Biosimilarity and Interchangeability
10.3.1.2 FDA Regulations Biosimilars Approval and Regulation
10.3.1.3 Demonstration on Basis of Data
10.3.1.4 12 Years of Market and Data Exclusivity
10.3.1.5 Resolution to Patent Dispute
10.3.1.6 Notice of Commercial Marketing to Reference Product Sponsor
10.3.1.7 Substitution of Small Molecular Products
10.4 Differences between FDA & the EMEA
10.5 Issues with Momenta
11. Factors Determining Market Entry in the Global Biosimilar Industry
11.1 Long Drawn-out Biosimilar Clinical Development Timeline
11.2 Approval Pathways for Biosimilars
11.3 High Development Costs of Biosimilars
11.3.1 Costs in Developed Markets
11.4 Biosimilars Manufacturing in Developing Countries – Pros & Cons
11.4.1 Issues with Regulatory Approval
11.4.2 Clinical Trials
11.4.3 Cost of Research & Development
11.4.4 Manufacturing Barriers
11.5 Proving of ‘Biosimilarity’
11.6 Issues with EMA Draft Guidelines for Biosimilar MAb Approval
11.7 Challenges with Patents
11.8 Role of Market Exclusivity for Branded Biologics
11.9 Strategic Partnerships Driving the Industry
11.9.1 Role of M&A Deals
11.9.1.1 Merck & Co.
11.9.1.2 Pfizer
11.10 Lack of Proper Safety Regulations
12. Biosimilar Approval Pathways in the US and Europe
13. Competitive Landscape
13.1 Key Industry Players
13.2 Key Industry Suppliers
13.3 Generic Drug Producers
13.4 Key Investors in the Industry
13.5 Major Stakeholders in the Industry
13.6 Developed versus Emerging Markets
13.7 Biosimilar Launches
13.8 Analysis by Markets
13.8.1 Biosimilars in Australia
13.8.2 Biosimilars in BRIC Countries
13.8.3 Biosimilars in the European Union (France, Germany, Italy, Spain, the UK)
13.8.4 Biosimilars in Japan
13.8.5 Biosimilars in United States
14. Analysis of Major Biosimilars
14.1 Epoetin
14.2 Filgrastim
14.3 Somatropin
15. Upcoming Patent Expiries and Opportunities for Biosimilars
16. Strategies of Big Pharma to Combat Biosimilars
17. Country-wise Biosimilar Market Analysis
17.1 France
17.1.1 Overview of the Healthcare System
17.1.2 Pricing and Reimbursement
17.1.3 Drivers & Challenges for Biosimilars in France
17.2 Germany
17.2.1 Overview of the Healthcare System
17.2.2 Pricing and Reimbursement
17.2.3 Drivers & Challenges for Biosimilars in Germany
17.3 India
17.4 Italy
17.4.1 Overview of the Healthcare System
17.4.2 Pricing and Reimbursement
17.4.3 Drivers & Challenges for Biosimilars in Italy
17.5 Japan
17.6 Spain
17.6.1 Overview of the Healthcare System
17.6.2 Pricing and Reimbursement
17.6.3 Drivers & Challenges for Biosimilars in Spain
17.7 United Kingdom
17.7.1 Overview of the Healthcare System
17.7.2 Pricing and Reimbursement
17.7.3 Drivers & Challenges for Biosimilars in the UK
17.8 United States
18. Major Industry Players
18.1 Dr. Reddy’s Laboratories Limited
18.1.1 Company Overview
18.1.2 Business Segments
18.1.3 Presence in Biosimilars Market
18.1.4 SWOT Analysis
18.2 Hospira Inc
18.2.1 Company Overview
18.2.2 Business Segments
18.2.3 Presence in Biosimilars Market
18.2.4 SWOT Analysis (Brief Analysis)
18.3 Sandoz International
18.3.1 Company Overview
18.3.2 Business Segments
18.3.3 Presence in Biosimilars Market
18.3.4 SWOT Analysis
18.4 STADA Arzneimittel AG
18.4.1 Company Overview
18.4.2 Business Segments
18.4.3 Presence in Biosimilars Market
18.4.4 SWOT Analysis
18.5 Teva Pharmaceutical Industries
18.5.1 Company Overview
18.5.2 Business Segments
18.5.3 Presence in Biosimilars Market
18.5.4 SWOT Analysis
18.6 Watson Pharmaceuticals
18.6.1 Company Overview
18.6.2 Business Segments
18.6.3 Presence in Biosimilars Market
18.6.4 SWOT Analysis
18.7 3SBio Inc.
18.8 Biocon Limited
18.9 Biopartners Gmbh
18.10 Celltrion Inc
18.11 Intas Biopharmaceuticals
18.12 Kyowa Hakko Kirin Co., Ltd.
18.13 Reliance Life Sciences
18.14 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
18.15 Wockhardt
19. Global Biosimilars Market Outlook
19.1 Market Outlook
19.2 Forecast for Biosimilar Sales
19.3 Forecast for US Biosimilars Market
19.4 Forecast for European Biosimilars Market
19.5 Forecast for Japanese Biosimilars Market
19.6 Forecast for Biosimilars
19.6.1 Biosimilars for Monoclonal Antibodies against Cancer
19.6.2 Erythropoietin (EPO) Biosimilars Markets
19.6.3 Human Growth Hormone (hGH) Biosimilars Markets
19.6.4 Granulocyte – Colony Stimulating Factor (G-CSF) Biosimilars Markets
19.6.5 Insulin and Insulin Analogs Biosimilars
19.6.6 Interferon alfa Biosimilars
19.6.7 Interferon beta Biosimilars
19.6.8 TNF alfa Inhibitor Biosimilars
20. Appendix
21. Glossary
【レポート販売概要】
■ タイトル：バイオシミラーのグローバル市場動向■ 英文：Global Biosimilars Industry
■ 発行日：2014年5月
■ 調査会社：Taiyou Research
■ 商品コード：Taiyou-40619074
■ 調査対象地域：グローバル
- グローバル包装（パッケージング）市場におけるトップ10企業分析Synopsis The Canadean Global Top 10 Packaging Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global packaging industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Stora Enso Oyj Amcor Limited Svenska Cellulosa Aktiebola …
- IoTにおけるビックデータ市場機会分析Today billions of devices generate data associated with various enterprise and consumer lifestyle events such as shopping activity, utility usage and other smart grid data, advertisement response, status of goods in transport, weather forecasts, traffic conditions, unscheduled and schedule maintenance of vehicles, aviation delays and timings, downloads and usage of applications, and much more. Dat …
- 消化酵素サプリメントの世界市場About Digestive Enzyme SupplementsDigestive enzymes are substances produced by a human body that aid in digestion of food. In cases of individuals, where there are insufficient enzymes, digestive enzyme supplements are consumed to assist digestion. Technavio’s analysts forecast the global digestive enzyme supplements market to grow at a CAGR of 5.23% during the period 2017-2021. [Covered in this r …
- 世界の通信業界における地理情報システム（GIS）市場：GISソフトウェア/データ/サービスAbout GIS A GIS is a system or a set of tools used to interpret business and geospatial data. It integrates hardware, software, and data for processing business and geographically referenced data. This system digitizes the received geospatial data and processes them to provide the desired output. GIS is used across various sectors, such as Natural Resources, Utilities, Federal Government, Communic …
- 筋萎縮性側索硬化症（Amyotrophic Lateral Sclerosis）：グローバル臨床試験動向（2014年上半期）Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2014" provides data on the Amyotrophic Lateral Sclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Amyotrophic Lateral Sclerosis. It includes an overv …
- Pine Cliff Energy Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Pine Cliff Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pine Cliff Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 歯車ポンプの世界市場2017-2020About Gear PumpGear pumps are major types of hydraulic pumps. These are used in mobile and industrial applications. Technavio’s analysts forecast the global gear pump market to grow at a CAGR of 4.02% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global gear pump market for 2017-2021. To calculate the market size, the r …
- RFID Solutions and Market OpportunitiesRFID Solutions and Market Opportunities is the most comprehensive RFID research package available in the market. It includes many reports in the core area of RFID as well as Near Field Communications (NFC), Personal Area Networks (PAN), Ultra-wide Band (UWB), and related areas (see Table of Contents for full list). This package represents complete market knowledge for service providers, suppliers, …
- 超純水の世界市場：超純水装置/材料/サービス、超純水用途、地域別分析The ultrapure water market is projected to reach USD 7.15 Billion by 2020, at a CAGR of 7.8% between 2015 and 2020. The key factor driving this growth is its increased usage in the semiconductor manufacturing industry. The semiconductor industry contributed a major share in the ultrapure water market in 2015, due to the increased usage of ultrapure water in the wafer fabrication process and clean …
- 冷媒の世界市場：フルオロカーボン系冷媒、無機冷媒、炭化水素The refrigerants market is projected to register a CAGR of 6.0% between 2015 and 2020 to reach $21 billion. Increasing demand of cooling products, high growth in Asia-Pacific region and growing cold chain market are the main growth drivers for refrigerant market. Asia-Pacific is the fastest growing region in the global refrigerants market. The countries dominating in the Asia-Pacific region are Ch …
- 風力タービン用ギアボックスの世界市場2015-2019About Wind Turbine Gearbox A gearbox as a part of a wind turbine is used to step up the rotor speed to the generator speed. The gears in a gearbox connect the low-speed shaft to the high-speed shaft, resulting in high rotational speed of generator shaft from the low rotational speed of turbine blades. The gearbox in a wind turbine does not change gears; it maintains a single-gear ratio between the …
- バイタルサインモニタリング装置の世界市場：体温、血圧、パルスオキシメーターAbout Vital Signs Monitoring Devices Vital sign monitors are used to measure body temperature, heart rate, respiration rate, and blood pressure. Vital signs can be measured, monitored, and observed with the use of several diagnostic devices. These devices have applications in both fitness monitoring and medical diagnostics. It also provides information related to abnormalities of a patient to medi …
- インダストリアル・インターネットの世界市場：M2M、スマートデバイス、ビックデータ分析、IoTの将来The Industrial Internet market is set for accelerated growth in 2015 as more businesses realize its potential uses and the positive impact it can have upon various industry verticals. The Industrial Internet market has already gained momentum with increasing adoption, offering a wide variety of uses and portfolio of applications, which is expanding sizeably. The main attraction offered by the Indu …
- 医療放射線遮蔽の世界市場：X線撮影室、シールド、ブース、シート、鉛、レンガ、カーテンThe global medical radiation shielding market is expected to reach USD 1330.0 Million by 2021 from USD 989.2 Million in 2016, at a CAGR of 6.1%. This market is segmented based on product, solution, and end user. The global medical radiation shielding market includes product, solutions, and end user. A number of factors, such as the growing incidences of cancer, increasing usage of nuclear medicine …
- 世界のシロップ及びスプレッド市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global syrups & spreads market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global syrups & spreads market throughout the month. Additionally, the report provides an overview of al …
